We believe this site might serve you best:

United States

English Continue

This country code will remain if no action is taken to change it.

Don't see your country?
Promega Corporation

Automation of Luminescence-Based CYP Inhibition Assays Scientific Poster

SEARCH POSTERS

Abstract

Brad Larson1, Peter Banks1, Jason Greene1, Sarah Shultz2, Jim Cali2, Mary Sobol2 and Simon Allard2
1BioTek Instruments, Inc., Winooski, VT
2Promega Corporation, Madison, WI

The ability to determine the effects that lead compounds have on cytochrome P450 enzymes is an important part of today's drug discovery routine. One desired component of this process is the ability to profile enzymes using the same basic procedure. The second is an easy, yet dependable way to dilute compounds that will create accurate titration curves. Here we demonstrate the automation of dose-response curves using BioTek's Precision™ XS automated pipetting system. IC50s of small molecule drugs were determined using recombinant CYP isoforms 3A4, 2C9 and 2D6 and luminogenic substrates specific to each from Promega's P450-Glo™ CYP450 Screening Systems. Compounds were profiled against all three isoforms on the same 384-well assay plate to demonstrate the ease of this combined procedure.

Document Icon Download the poster PDF (545kb)

  • Part# PS090
  • Printed in USA.

It appears that you have Javascript disabled. Our website requires Javascript to function correctly. For the best browsing experience, please enable Javascript.

Scientists at Your Service

Scientists at Your Service

We offer a range of services to help you succeed using Promega technologies. From product training to set up of automated systems and development of custom applications—our scientific support goes beyond the basics.

Ask us! We are here to help you.